1. 3D Map Reconstruction of an Orchard using an Angle-Aware Covering Control Strategy. Issue 32 (2022) Authors: Mammarella, Martina; Donati, Cesare; Shimizu, Takumi; Suenaga, Masaya; Comba, Lorenzo; Biglia, Alessandro; Uto, Kuniaki; Hatanaka, Takeshi; Gay, Paolo; Dabbene, Fabrizio Journal: IFAC-PapersOnLine Issue: Volume 55:Issue 32(2022) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab. Issue 7 (25th July 2022) Authors: Saito, Naoto; Hatanaka, Takeshi; Nakano, Sachi; Hazama, Yoichi; Yoshida, Sachiko; Hachisu, Yoko; Tanaka, Yoshiki; Yoshinaga, Teruo; Kashiwabara, Kenji; Kubo, Norio; Hosouchi, Yasuo; Tojima, Hiroki; Kakizaki, Satoru; Uraoka, Toshio Journal: Clinical case reports Issue: Volume 10:Issue 7(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A distributed singular perturbation algorithm in a non-cooperative game under limited control authority. Issue 23 (2018) Authors: Nguyen, Chuong Van; Hatanaka, Takeshi; Ahn, Hyo-Sung Journal: IFAC-PapersOnLine Issue: Volume 51:Issue 23(2018) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Modularized Design for Output Synchronization of LTI Dynamical Networks with Communication Delays. Issue 6 (1st November 2018) Authors: Dan, Hayato; Hatanaka, Takeshi; Shim, Hyungbo Journal: SICE journal of control, measurement, and system integration Issue: Volume 11:Issue 6(2018) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Passivity-Based Distributed Reference Governor for Constrained Robotic Networks *. Issue 1 (July 2017) Authors: Nguyen, Tam; Hatanaka, Takeshi; Doi, Mamoru; Garone, Emanuele; Fujita, Masayuki Journal: IFAC-PapersOnLine Issue: Volume 50:Issue 1(2017) Page Start: 15434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab. (14th December 2022) Authors: Tada, Toshifumi; Kumada, Takashi; Hiraoka, Atsushi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimu... Journal: Cancer medicine Issue: Volume 12:Number 7(2023) Page Start: 7772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study. Issue 3 (10th December 2019) Authors: Hatanaka, Takeshi; Kakizaki, Satoru; Nagashima, Tamon; Namikawa, Masashi; Tojima, Hiroki; Shimada, Yasushi; Takizawa, Daichi; Naganuma, Atsushi; Arai, Hirotaka; Sato, Ken; Harimoto, Norifumi; Shirabe, Ken; Uraoka, Toshio Journal: Hepatology research Issue: Volume 50:Issue 3(2020) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis. Issue 5 (9th February 2022) Authors: Hatanaka, Takeshi; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishi... Journal: Hepatology research Issue: Volume 52:Issue 5(2022) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience. Issue 2 (11th June 2021) Authors: Hiraoka, Atsushi; Kumada, Takashi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimu... Journal: Cancer reports Issue: Volume 5:Issue 2(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. (February 2023) Authors: Casadei-Gardini, Andrea; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Rimassa, Lorenza; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamo... Journal: European journal of cancer Issue: Volume 180(2023) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗